Navigation Links
Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer
Date:12/13/2007

Oral Presentation of the US Oncology Adjuvant Trial 9735 at 2007 San Antonio Breast Cancer Symposium Showed Taxotere(R) and Cyclophosphamide

Improved Overall Survival Versus An Anthracycline Combination

SAN ANTONIO, Dec. 13 /PRNewswire-FirstCall/ -- Results presented at the 30th annual San Antonio Breast Cancer Symposium (SABCS) showed that for women with early stage breast cancer who have had surgery, treatment with the investigational chemotherapy combination of Taxotere(R) (docetaxel) Injection Concentrate and cyclophosphamide significantly improved overall survival compared to standard chemotherapy. The presentation reports results with a median follow-up of seven years and has been updated since the last report was published with 5.5 years median follow-up [Jones S et al. J Clin Oncol, 2006, 24:5381-7]. This latest report has also been updated from the abstract submitted to SABCS 2007.

In the updated analysis, overall survival at seven years was statistically higher among women treated with Taxotere(R) and cyclophosphamide (TC) versus those treated with doxorubicin and cyclophosphamide (AC): 87% versus 82% (HR: 0.69, [95% CI, 0.50, 0.97]). The 31% reduction in the risk of death was statistically significant (p=0.032). At seven years, the disease-free survival (DFS) was also statistically greater among women treated with TC than those treated with AC: 81% versus 75% (HR: 0.74, [95% CI, 0.56, 0.98]). The 26% reduction in the risk of cancer recurrence among women treated with TC was statistically significant (p=0.033). The disease-free survival benefit seen in the elderly patients (aged 65 years or older; 31% risk reduction of recurrence) is consistent with that in the overall patient population.

Principal study investigator Dr. Stephen Jones, medical director and co-chair, breast cancer research committee of US Oncology, helped develop the regimen combining the anthracycline doxorubicin with cyclophosphamide, which became a
'/>"/>

SOURCE sanofi-aventis
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs
2. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
3. Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium
4. Brostallicin Trial Data Demonstrates Encouraging Anti-tumor Activity in Patients With Chemotherapy-Resistant Cancers
5. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
6. Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy
7. Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo
8. UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients
9. New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo
10. Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety
11. Varian Medical Systems Introduces New and Improved VariSeed(TM) 8.0 Software for Permanent Seed Prostate Brachytherapy Treatments

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... -- Gone hybrid . . . , Fuel economy ratings f...ted at the www.fueleconomy.gov web site, which O...ns for the U.S. Department of Energy and the U.S. ...0 vehicles on the best fuel economy list are hybri... 48 highway). "This list proves that hybrids have ...
(Date:11/5/2009)...olo., Nov. 5 The endangered black-...stern U.S. This rare carnivore feeds on prairie d...ague and often entire population die-offs in towns...) has implemented a ferret breeding program and ha...ir formerly native habitat. Unfortunately, plague...
(Date:11/5/2009)...v. 5 Imagenetix, Inc. (O...liam Spencer, President and CEO of Imagenetix, wil...ual LD MICRO Conference on Thursday, December 3rd,.... ,, About LD MICRO ,, LD MICRO is a by-invi...g undervalued companies in the micro-cap space. Si...
(Date:11/5/2009)...ll on Thursday, November 5, 2009 at 4:30 p.m. East...PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals,...I ) today reported unaudited financial results for... 30, 2009 and reviewed the Company,s highlights fo...onsolidated results reflect the operations of Onco...
Breaking Biology Technology:November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
..., VANCOUVER, Feb. 9 /PRNewswire-FirstCall/ - iCo T...ce the completion of a $1,292,500 non-brokered pri...y with sufficient capital to develop iCo-007 throu.... iCo-007 is targeting the treatment of Diabetic M...e company with additional working capital. iCo,s p...
..., ST. LOUIS, Feb. 9 Solutia Inc. (NYSE: SOA... president and CEO, will address,investors at the ... p.m.,Eastern time on Wednesday, February 11, 2009...ion and a replay will be available on the investor...o: http://www.newscom.com/cgi-bin/prnh/20081029/...
..., CALGARY, Feb. 9 /PRNewswire/ - Orcrist Bio Inc. ...izing pharmaceuticals, announced today that it has...ville, Spain, a Phase I, open-label, single-ascend...olunteers. The goal of the study is to assess the ...odynamics (induction of hematopoiesis) of HYC750, ...
Other Biology Technology:iCo Therapeutics Closes $1.3 Million Private Placement 2iCo Therapeutics Closes $1.3 Million Private Placement 3Solutia to Present at Deutsche Bank Small and Mid Cap Conference 2Orcrist Bio Inc. Files with European Competent Authority for a Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750 2Orcrist Bio Inc. Files with European Competent Authority for a Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750 3
(Date:11/5/2009)...ociation of Biology Teachers (NABT) will recognize...ences at Naugatuck Valley Community College (NVCC)...n Education Award during the NABT annual professio...er 2009 in Denver, Colorado. , The Evolution Edu...ute of Biological Sciences,(AIBS) and Biological ...
(Date:11/5/2009)...rsity has been awarded a training grant in the amo...on under its Integrative Graduation Education and ...st IGERT grant to be awarded to Kent State. The gr...nd Reinvestment Act of 2009, runs through 2014. ,... environment aquatic resource sensing (EARS). The ...
(Date:11/4/2009)...ews in natural science) , United States Using ...water today than it did 35 years ago, despite a 30...e are partly attributable to alternative cooling m...on systems. According to the latest USGS water use...ed States goes to cooling thermoelectric power pla...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Radiation From Medical Scans Soaring 60144 1Radiation From Medical Scans Soaring 60144 2Radiation From Medical Scans Soaring 60144 3National Family Partnership Calls on Parents to Lock Your Meds 60140 1National Family Partnership Calls on Parents to Lock Your Meds 60140 2National Family Partnership Calls on Parents to Lock Your Meds 60140 3National Family Partnership Calls on Parents to Lock Your Meds 60140 4CSC Wins DHS IT Infrastructure and Cyber Security Task Order 60136 1CSC Wins DHS IT Infrastructure and Cyber Security Task Order 60136 2
...uality at beaches along the Great Lakes have promp...safe for recreation. A new collaborative project i...s when they are faced with deciding whether to clo...ative effort will draw on the expertise of U.S. Ge... agencies. , The project has been funded through...
...able in Spanish . , , Breaking up the dosage of...ces the quality of wheat and limits its negative e...of the PhD thesis of University of the Basque Coun..., presented at the Faculty of Science and Technolo...des, more concretely during the second half of the...
...ATE RELEASE , New-generation artificial cornea c...chnology Progress , An improved artificial corne...million people worldwide who are blind due to dise...ientists in California conclude in a new analysis ... for the June 6 issue of ACS, Biotechnology Progre...
Other Biology News:To swim or not to swim? 2Dosage of fertilizer helps to enhance quality of wheat 2Dosage of fertilizer helps to enhance quality of wheat 3American Chemical Society's Weekly PressPac -- May 14, 2008 2American Chemical Society's Weekly PressPac -- May 14, 2008 3American Chemical Society's Weekly PressPac -- May 14, 2008 4American Chemical Society's Weekly PressPac -- May 14, 2008 5American Chemical Society's Weekly PressPac -- May 14, 2008 6American Chemical Society's Weekly PressPac -- May 14, 2008 7American Chemical Society's Weekly PressPac -- May 14, 2008 8
...Capture high-resolution chemiluminescent and biolu...em. High-sensitivity camera is cooled to subzero t...e dynamic range for high quality images in a short...ptimum conditions for chemiluminescence and includ...
...nucleotide) Genome Set and MEEBO (Mouse Exonic Evi... collection of open source oligo probes, largely d...ng interrogation of thousands of genes. Developed ...ord University and UCSF, the sets enable the study...
Rabbit Anti-FANCE Polyclonal Antibody, Unconjugated from Abcam
Alu I from New England Biolabs
Biology Products: